Race-specific geography of prostate cancer incidence

被引:23
作者
DeChello L.M. [1 ]
Gregorio D.I. [1 ]
Samociuk H. [1 ]
机构
[1] Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT 06030-6325
关键词
Prostate Cancer; Geographic Variation; Census Tract; Residential Segregation; Prostate Cancer Incidence;
D O I
10.1186/1476-072X-5-59
中图分类号
学科分类号
摘要
Background: This study evaluated geographic distribution of race-specific prostate cancer incidence in Connecticut and Massachusetts. This cross-sectional analysis of census and cancer registry data included records of 29,040 Whites and 1,647 African Americans diagnosed with incident prostate cancer between 1994 and 1998. A spatial scan statistic was used to detect and test significance of the geographic variation in race-specific incidence rates within the two-state area. Results: Significant geographic variation in age-adjusted incidence rates among both White and African American men was observed, with little overlap noted between distributions. Identified locations reflected patterns of residential segregation and socio-economic conditions. Among Whites, places with higher than expected incidence had higher socioeconomic status than places with lower than expected incidence. No discernable relationship between social indicators and rate variation among African Americans was evident. Conclusion: Differences in race-specific geographic distribution of prostate cancer incidence do not suggest a shared environmental etiology. Furtherstudyof genetic, behavioral and health carefactors affecting the occurrence and/or reporting of the disease is warranted. This study highlights the need for race- and geographic-specific interventions to better control disease within at-risk communities and for on-going analysis into social and contextual factors that contribute to observed disparities between African Americans and Whites in the occurrence of cancer. © 2006 DeChello et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 27 条
[1]  
Haas G.P., Sakr W.A., Epidemiology of prostate cancer, CA Cancer J Clin, 47, pp. 273-287, (1997)
[2]  
Brawley O.W., Knopf K., Thompson I., The epidemiology of prostate cancer part II: The risk factors, Semin Urol Oncol, 16, 4, pp. 193-201, (1998)
[3]  
Spencer B.A., Babey S.H., Etzioni D.A., Ponce N.A., Brown E.R., Yu H., Chawla N., Litwin M.S., A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma, Cancer, 106, 4, pp. 765-774, (2006)
[4]  
Jemal A., Ward E., Wu X., Martin H.J., McLaughlin C.C., Thun M.J., Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States, Cancer Epidemiol Biomarkers Prev, 14, 3, pp. 590-595, (2005)
[5]  
Gregorio D.I., Kulldorff M., Sheehan T.J., Samociuk H., Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998, Urology, 63, 1, pp. 78-82, (2004)
[6]  
Rogerson P.A., Sinha G., Han D., Recent changes in the spatial pattern of prostate cancer in the U.S, Am J Prev Med, 30, 2 SUPPL., (2006)
[7]  
Powell I.J., Prostate cancer in the African American: Is this a different disease?, Semin Urol Oncol, 16, 4, pp. 221-226, (1998)
[8]  
Cancer Facts & Figures for African Americans, 2005-2006, (2005)
[9]  
Brawley O.W., Knopf K., Merrill R., The epidemiology of prostate cancer part I: Descriptive epidemiology, Semin Urol Oncol, 16, pp. 187-192, (1998)
[10]  
Rushton G., Methods to evaluate geographic access to health services, J Public Health Manag Pract, 5, pp. 93-100, (1999)